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Edited by Veli-Pekka LehtoAbstract In this study the n  3 polyunsaturated fatty acids
(PUFAs) eicosapentaenoic acid and docosahexaenoic acid ap-
pear to be eﬀective inducers of electrophile-responsive element
(EpRE) regulated genes, whereas the n  6 PUFA arachidonic
acid is not. These n  3 PUFAs need to be oxidized to induce
EpRE-regulated gene expression, as the antioxidant vitamin E
can partially inhibit the PUFA induced dose-dependent eﬀect.
Results were obtained using a reporter gene assay, real-time
RT-PCR and enzyme activity assays. The induction of EpRE-
regulated phase II genes by n  3 PUFAs may be a major path-
way by which n  3 PUFAs, in contrast to n  6 PUFAs, are
chemopreventive and anticarcinogenic.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Epidemiological and experimental studies have demon-
strated that n  3 polyunsaturated fatty acids (PUFAs) reduce
colon cancer risk [1–4]. However, the mechanisms by which
n  3 PUFAs reduce cancer risk are still a matter of debate
[5]. Several mechanisms for the chemopreventive characteris-
tics of n  3 PUFAs have been postulated in the literature:
metabolism of fatty acids to the biologically active prostaglan-
dins, regulation of the peroxisome proliferator-activated recep-
tor alpha, changes in membrane composition – which could
aﬀect cell signaling pathways –, and increase of oxidative stress
[6–8]. In contrast to n  3 PUFAs, n  6 PUFAs seem to have
no chemopreventive characteristics. Moreover, it has been re-Abbreviations: AA, arachidonic acid; DHA, docosahexaenoic acid;
EPA, eicosapentaenoic acid; EpRE, electrophile-responsive element;
GST(P1), glutathione S-transferase (Pi 1); Keap1, Kelch-like ECH-
associated protein 1; MT1, metallothionein 1; NQO1, NAD(P)H:
quinone oxido-reductase 1; Nrf2, NF-E2-related factor 2; PUFA,
polyunsaturated fatty acid
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[9,10].
When regarding oxidative stress, the adaptation of cells to
this stress is critical. Foremost is the transcriptional regula-
tion of antioxidant enzymes, many of which are controlled
by an electrophile-responsive element (EpRE) enhancer ele-
ment, also known as an antioxidant-responsive element
[11]. The major transcription factor involved in EpRE-medi-
ated gene transcription regulation is NF-E2-related factor 2
(Nrf2) [12,13]. Under normal conditions, Nrf2 is sequestered
by binding to the cysteine-rich Kelch-like ECH-associated
protein 1 (Keap1). Inducers can react with the cysteine thiols
of Keap1 leading to a conformational change and subsequent
release of Nrf2, allowing interaction with EpRE elements
[12–16]. One of these inducers is a member of the J-series
cyclopentenone prostaglandins. These compounds are analo-
gous to isoprostanes, which are formed during non-enzy-
matic lipid peroxidation of PUFAs, suggesting a possible
relation between oxidation of PUFAs and EpRE induction
[11,17].
Besides antioxidant enzyme genes, EpREs also regulate
genes encoding phase II detoxiﬁcation enzymes [13]. These
phase II enzymes play an important role in determining the
ﬁnal fate of carcinogens/procarcinogens and their subsequent
impact on carcinogenesis [18,19]. Therefore, the induction of
phase II enzymes is considered a major process in cancer pre-
vention [20].
To determine whether PUFAs can induce EpRE-mediated
genes, the EpRE (mGST-Ya)-LUX cell line was used, which
is stably transfected with an EpRE-controlled luciferase repor-
ter gene [21]. This reporter cell line originates from the mouse
hepatoma cell line Hepa-1c1c7, and makes use of an EpRE ele-
ment from the mouse glutathione S-transferase-Ya EpRE gene
regulatory region.2. Materials and methods
2.1. Cultivation of the mouse EpRE(mGST-Ya)-LUX cell line
The transfected luciferase reporter cell line EpRE(mGST-Ya)-LUX
was developed as described by Boerboom et al. [21]. The cells were cul-
tivated in minimum essential medium a (MEM-a) medium, supple-
mented with (v/v): 10% fetal calf serum, 1% 250 lg ml1
amphotericin B, and 0.1% 50 mg ml1 gentamicin. The cells were
maintained in an atmosphere of 5% CO2/95% air at 37 C with a
humidity of 100%. After reaching 70–90% conﬂuence in 75 cm2 culture
ﬂasks, the cells were sub-cultured at a ratio of 1:5.blished by Elsevier B.V. All rights reserved.
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The trypsinized EpRE(mGST-Ya)-LUX cells were diluted with cul-
ture medium to a concentration of 2 · 105 cells ml1. After 24 h of
growth, the cells were exposed to MEM-a medium containing:
1 mg ml1 fatty acid-free bovine serum albumin (BSA), the indicated
concentrations of the fatty acid to be tested, and, when applicable,
100 lM vitamin E. If applicable, the cells were pre-incubated with anti-
oxidant vitamin E during the ﬁrst 24 h of growth. The fatty acids were
added to the medium as a solution in ethanol; the ﬁnal concentration
of ethanol in the medium of 0.5%. Before addition to the cells, the fatty
acids were pre-incubated in the BSA-containing medium at 37 C for
30 min. The positive control wells received exposure medium contain-
ing a ﬁnal concentration of 40 lM tert-butyl hydroquinone (tBHQ) in
ethanol instead of the fatty acid solution.2.3. EpRE-LUX assay
The EpRE(mGST-Ya)-LUX cells were exposed in a Packard View-
Plate-96. After 24 h of exposure the plate was rinsed with 0.5· phos-
phate-buﬀer saline. Subsequently, the cells were lysed by adding 30 ll
of a hypotonic low-salt buﬀer (10 mM Tris/HCl, pH 7.8, 2.0 mM 1,2-
diaminocyclo-hexane-tetraacetic acid, and 2.0 mM dithiothreitol) per
well. The plate was put on ice for 10 min, and frozen at 80 C for
1 h. Before analysis and protected from light, the plate was thawed
on ice for 30 min and subsequently, it was gently shaken to reach room
temperature. Luminescence was analyzed using a Luminoskan (Ther-
mo Labsystems, Altricham, UK) with the following protocol for each
well: measurement of the background light emission for 2 s, addition
of 100 ll ﬂashmix (20 mM Tris/HCl, pH 7.8, 1.07 mM MgCO3,
2.67 mM MgSO4, 0.1 mM EDTA, 2 mM DTT, 470 lM D-luciferin,
5 mMATP), measurement of the light emission for 2 s, and termination
of the light reaction by addition of 50 ll of 0.2 M NaOH.
2.4. Real-time quantitative RT-PCR analysis
RNA was isolated from exposed EpRE(mGST-Ya)-LUX cell culti-
vations, grown in 25 cm2 culture ﬂasks, using Trizol according to the
manufacturer’s protocol (Invitrogen), and puriﬁed using the Qiagen’s
RNeasy Mini Kit and RNase-Free DNase Set. First-strand cDNA syn-
thesis was carried out with an oligo(dT)15 primer and Moloney murine
leukemia virus reverse transcriptase (Promega); during synthesis the
recombinant ribonuclease inhibitor RNaseOUT (Invitrogen) was
present. The ampliﬁcation reaction was carried out on a LightCycler
(Roche Diagnostics) with gene-speciﬁc primers and used the SYBR
Green 1 protocol. The following LightCycler protocol was used:
15 min heat start at 95 C; 45 cycles of denaturation at 95 C for
30 s, annealing at the optimal annealing temperature for the primer
set for 30 s, and extension at 72 C for 45 s; and a terminal extension
at 72 C for 5 min. Fluorescence detection was carried out at 72 C.
The Bio-Rad Gene Expression Macro (DDCT) was used for analysis.
Relative expression ratios were normalized to the housekeeping gene
b-actin. The primer sequences are available on request.2.5. NQO1 and GST activity assay
EpRE(mGST-Ya)-LUX cells were exposed in six-well tissue culture
plates. After 24 h of exposure the cells were trypsinized and resus-
pended in MEM-a medium. This cell suspension was centrifuged for
5 min at 80 · g. Then, the supernatant was decanted and the cell pellet
resuspended in 20 mM Tris/HCl, pH 7.5. The cells were lysed using a
Bandelin Sonorex RK100 for 5 min. Again, the samples were centri-
fuged again for 5 min at 80 · g. The total amount of protein in the
cell-free extracts was determined using the bicinchoninic acid assay
(Pierce) with bovine serum albumin as a standard.
For the NAD(P)H:quinone oxido-reductase 1 (NQO1) measure-
ments, an adaptation of the assay as described by Ernster [22] and
modiﬁed by Benson et al. [23], was used with 2,6-dichlorophenolindo-
phenol (DCPIP) as a substrate. The reaction mix contained: 20 mM
Tris/HCl, pH 7.5, 0.01% Tween 20 (v/v), 0.07% BSA (w/v), 200 lM
NADH, 2% cell-free extract (v/v), and 40 lMDCPIP; assays were car-
ried out in the presence or absence of 20 lM dicumarol. NQO1 activity
is described as the dicumarol-inhibitable decrease in absorbance at
600 nm with DCPIP as a substrate and is expressed in nanomoles of
DCPIP reduced per minute per milligram of protein.
For the GST measurements, an adaptation of the assay as described
by Habig et al. [24] was used with 1-chloro-2,4-dinitrobenzene
(CDNB) as a substrate. The reaction mix contained: 100 mM potas-sium phosphate, pH 6.5, 1 mM CDNB, 1 mM reduced glutathione
and 2% cell-free extract (v/v). GST activity is described as the increase
in absorbance at 340 nm with CDNB as a substrate and is expressed in
nanomoles of CDNB–glutathione conjugate formed per minute per
milligram of protein.
2.6. Statistics
Statistical signiﬁcance was tested using a one-tailed homoscedastic
Student’s t test. The a level was set at 0.05.3. Results and discussion
The EpRE(mGST-Ya)-LUX cell line was exposed to the
n  3 PUFAs eicosapentaenoic acid (EPA) and docosahexae-
noic acid (DHA), and the n  6 PUFA arachidonic acid
(AA) in a concentration range of 0–100 lM for 24 h. EPA
and DHA were selected as these are the most abundant
n  3 PUFAs in the human diet. AA was chosen as an n  6
PUFA because it is also present in the human diet and resem-
bles EPA and DHA the most with respect to fatty acid chain
length and saturation. The concentrations used are within
range of the normal PUFA concentration in blood plasma
[25]. After exposure the luciferase activity induced in the repor-
ter cells was measured; the results are expressed as an induc-
tion factor (Fig. 1A). To assess the necessity of PUFA
oxidation for the induction of EpRE-regulated gene transcrip-
tion, the antioxidant vitamin E was added at a concentration
of 100 lM (Fig. 1B). tBHQ, a standard inducer of EpRE-reg-
ulated gene transcription, was used as a positive control [26].
The results presented in Fig. 1A show a dose-dependent in-
crease in EpRE-controlled luciferase reporter gene expression
induced by n  3 PUFAs. Exposure to the highest concentra-
tion resulted in a large increase in luciferase induction of
almost 8-fold for DHA, and 4.5-fold for EPA. In contrast,
exposure to the highest concentration of the n  6 PUFA
AA gave only a small 2.1-fold increase in induction. DHA
and EPA started to diﬀer signiﬁcantly from AA from 20 lM
onwards: P = 0.0073 and P = 0.026, respectively. All together,
the results for this cell line show that ﬁrstly, all the tested PU-
FAs are able to induce EpRE-mediated luciferase. Secondly,
the n  3 PUFAs EPA and DHA induce EpRE-mediated lucif-
erase in a much higher fold change than the n  6 PUFA AA.
When comparing Fig. 1B to A, it is obvious that the anti-
oxidant vitamin E strongly decreases the luciferase induction
factor for all tested PUFAs. Exposed to the highest concentra-
tion of PUFA in the presence of 100 lM of vitamin E, the
inductions are 3.7-fold, 2.0-fold and 1.4-fold for DHA, EPA
and AA, respectively. Statistics show that the induction factors
for the n  3 PUFAs DHA and EPA in the absence of vitamin
E, start to diﬀer signiﬁcantly from the induction factors in the
presence of vitamin E: for DHA from 20 lM (P = 0.010) and
for EPA from 40 lM (P = 0.017) onwards. For the AA-medi-
ated induction vitamin E had no signiﬁcant eﬀect (P P 0.15).
These results clearly show that oxidation plays a major role in
the n  3 PUFAs’ ability to induce EpRE-regulated gene
expression.
Subsequently, the results of the reporter gene studies were
conﬁrmed by real-time PCR analysis of the eﬀect of n  3 and
n  6 PUFAs on the expression level of three known EpRE-reg-
ulated genes: glutathione S-transferase Pi 1 (GSTP1), NQO1,
and metallothionein 1 (MT1) [27,28] (Fig. 2). In addition, total
GST and NQO1 enzyme activity upon exposure to DHA, EPA,
Fig. 1. Induction of luciferase in EpRE(mGST-Ya)-LUX cells after 24 h of exposure to increasing concentrations of DHA, EPA and AA,
respectively (n = 4), expressed as the induction factor as compared to the solvent control, (A) in the absence of vitamin E and (B) in the presence of
100 lM vitamin E.
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and NQO1 genes at the protein level (Fig. 3). For both assays
the same cell line was used as for the luciferase assay.
Statistics show that using real-time RT-PCR (Fig. 2) the
induction by DHA signiﬁcantly diﬀers from the control for
all the three tested genes: GSTP1 (P = 3.5E05), NQO1
(P = 0.0041), and MT1 (P = 0.025). Also the induction by
EPA diﬀers signiﬁcantly from the control: GSTP1 (P =
8.5E05), NQO1 (P = 0.031), and MT1 (P = 6.5E08). AA
only signiﬁcantly (P = 0.027) diﬀers from the control in the case
of NQO1, but here there is repression instead of induction.
For the fold change of the enzymes (Fig. 3), only the n  3
PUFAs DHA and EPA signiﬁcantly diﬀer from the NQO1
control (P = 2.3E04 and P = 3.0E05, respectively). In theFig. 2. Fold change, determined by real-time RT-PCR, of the NQO1,
GSTP1 and MT1 mRNA levels in EpRE(mGST-Ya)-LUX cells after
24 h of exposure to 100 lM DHA, EPA and AA, respectively (n = 4),
as compared to the solvent control.
Fig. 3. Fold change of the enzyme activity of NQO1 and GST in
EpRE(mGST-Ya)-LUX cells after 24 h of exposure to 80 lM DHA,
EPA and AA, respectively (n = 4), as compared to the solvent control.case of GST, all the tested PUFAs are inducers
(P = 2.0E04, P = 1.9E04 and P = 0.0037 for DHA, EPA
and AA, respectively). However, the induction by AA is signi-
ﬁcantly lower than those of the n  3 PUFAs DHA and EPA
(P = 4.05E04 and P = 3.83E04, respectively).
When all the results that are shown in Figs. 2 and 3, are
compared, we conclude that the diﬀerential induction by
n  3 and n  6 PUFAs of EpRE-mediated genes is compara-
ble to the results obtained in the reporter gene assay: DHA has
the highest induction factor, followed by EPA, and then AA.
For all EpRE-regulated responses, except for the GST activity,
no induction by AA is observed.
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than the induction of the endogenous genes studied, but there
are several possible explanations that can account for this dif-
ference. The reporter assay was based on the EpRE element
from the regulatory region of the mouse GST-Ya gene, and
this element tends to mediate higher induction levels than the
EpRE element controlling expression of the NQO1 gene [21].
Moreover, the expression of the endogenous GSTP1 and
NQO1 genes is not only controlled by an EpRE element, as
is the case with the luciferase reporter gene, but by a more
complex regulatory region including additional regulatory se-
quences, which might explain these quantitative diﬀerences.
Our data on enzyme induction by n  3 PUFAs are in agree-
ment with recent observations by Arab et al. [29]. Upon
exposure of human ﬁbroblasts to DHA they found a dose-
dependant induction of mRNA and enzyme activities of c-glut-
amyl cysteinyl ligase, glutathione reductase, and glutathione
S-transferase, all involved in glutathione-homeostasis. On the
basis of the presence of a consensus EpRE(ARE) sequence
upstream of these genes they suggested a role for antioxidant-
responsive elements EpRE(ARE)-mediated transcription regu-
lation of the antioxidant response in ﬁbroblasts when exposed
to DHA. In our reporter gene study we provide conclusive evi-
dence for the EpRE(ARE)-mediated nature of the antioxidant
enzyme induction by the n  3 PUFADHA, and moreover, for
the ﬁrst time show that this is a clear and biological relevant dif-
ferential eﬀect as compared to n  6 PUFAs.
Altogether, we conclude that n  3 PUFAs are eﬀective
inducers of EpRE-regulated genes, while n  6 PUFAs are
not. The mechanism by which n  3 PUFAs can protect
against cancer might be the induction of EpRE-mediated
phase II detoxiﬁcation enzymes, thereby increasing the defense
capacity of the cells towards potential carcinogens [13,20]. The
presented results demonstrate that the induction of EpRE-
mediated cancer-protective gene expression by n  3 PUFAs
may be a major pathway by which n  3 PUFAs are chemo-
preventive and anticarcinogenic.
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